AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
Cas No: 335161-24-5
Formula: C24H22FNO
IUPAC: 1-[(5-fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone
Appearance:
Purity: 99.99%